From Our 2010 Archives
Study Looks At Cost-Effectiveness of ECG in Hyperactive Kids
Latest Healthy Kids News
MONDAY, March 8 (HealthDay News) -- Electrocardiogram screening to check for heart problems in hyperactive children before prescribing stimulant medications may help identify those at risk, but is only borderline cost-effective compared to the current practice of taking a patient history and doing a physical examination, a new study shows.
Stimulant medications -- such as Ritalin, Concerta and Adderall -- that are used to treat attention-deficit/hyperactivity disorder boost pulse rate and may increase the risk of sudden cardiac death in children with some types of heart conditions.
In this study, U.S. National Institutes of Health researchers used a cost-effectiveness model to compare three strategies:
Lives typically would be saved by barring at-risk children from playing sports, the researchers said.
"We're not making a recommendation, but providing one type of analysis so others can determine what makes sense in the real world," study co-author Dr. Jonathan Kaltman, a medical officer in the heart development and structural diseases branch of the U.S. National Heart, Lung, and Blood Institute, said in a news release.
The study findings are published in the March 8 online edition of the journal Circulation.
"Preventing sudden cardiac death in children is an important issue," Dr. Paul Matherne, chair of the American Heart Association's Council on Cardiovascular Disease in the Young, said in the news release. "While this study has limitations and is not conclusive, it does offer new approaches and insights that add to our understanding of preventing sudden death. Importantly, it highlights the need for more research into both screening to identify children at risk for sudden death, and for developing new therapies to treat these conditions."
-- Robert Preidt
Copyright © 2010 HealthDay. All rights reserved.
SOURCE: American Heart Association, news release, March 8, 2010